Quintiles

Quintiles Transnational, Inc
Public
Traded as NYSE: Q
Industry Contract Research Organization
Pharmaceutical Service Consulting
Founded 1982
Headquarters Durham, North Carolina, USA
Key people
Dennis Gillings, Founder
Tom Pike CEO
Kevin Gordon COO
Products Support services for pharmaceutical, biotech and medical companies and individuals
Revenue IncreaseUS$ Approximately $4.2 billion in Service Revenue (2014)
Number of employees
~ 35,000 (2015)
Website http://www.quintiles.com/

Quintiles Transnational, INC (NYSE: Q), is a Fortune 500 company and the world’s largest provider of biopharmaceutical development and commercial outsourcing services with a network of more than 35,000 employees conducting business in approximately 100 countries.

Quintiles is the world’s largest contract research organization[1] as ranked by reported service revenues, and is focused primarily on Phase II-IV clinical trials and associated laboratory and analytical services. The division of Quintiles Integrated Healthcare Services is an outsourcing partner for pharmaceutical companies to support sales and healthcare business services, such as outcome research and marketing.

History

In 1982, Dennis Gillings founded and incorporated Quintiles Transnational in North Carolina.[2]

Quintiles Transnational established Quintiles Pacific Inc. and Quintiles Ireland Ltd. in 1990,[3] and in 1991 Quintiles GmbH was established in Germany and Quintiles Laboratories Ltd. was established in Atlanta, Georgia.[4]

In September 1996, Quintiles purchased Innovex Ltd. of Britain for $747.5 million in stock.[5]

Quintiles went public in 1997 and completed a successful secondary stock offering.[6]

References

External links

This article is issued from Wikipedia - version of the Wednesday, May 04, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.